Quantcast

Latest Oncology Stories

2014-09-23 08:31:48

PLYMOUTH, Wis., Sept. 23, 2014 /PRNewswire/ -- Sartori Cheese will be releasing their Limited Edition Peppermint BellaVitano cheese for the month of October in support of breast cancer awareness month. The artisan cheese producer will donate a portion of all Peppermint BellaVitano proceeds to the National Breast Cancer Foundation, Inc.(®) To date, Sartori had donated over $20,000 to the foundation. http://photos.prnewswire.com/prnvar/20140922/147693 "Peppermint BellaVitano is a...

2014-09-23 08:30:28

#MBCStrength Encourages Women Living with Metastatic Breast Cancer to Share their Strength and Inspiration with Others WILMINGTON, Del., Sept. 23, 2014 /PRNewswire/ -- More than 173,000 women in the United States are living with metastatic breast cancer and each has a story to tell. AstraZeneca is launching a nationwide photo-sharing campaign to provide them another way to share their inspiration, experiences and strengths with others. To view the multimedia assets associated with...

2014-09-22 23:14:09

If a diagnosed victim of mesothelioma or their family members are concerned about making certain they know who the nation's most skilled mesothelioma compensation attorneys are, please call the Mesothelioma Victims Center at 866-714-6466 for on-the-spot information and instant access. This week the group is highlighting ScienceDaily.com as a great website for information on the best possible treatment options, as it is always being updated with news....

2014-09-22 23:10:40

New survey conducted by CML-IQ highlights need for CML awareness and increased resources for patients. Montreal, Quebec (PRWEB) September 22, 2014 Today has been designated World CML Day to broaden understanding of chronic myelogenous leukemia, a form of blood cancer that affects approximately 5,000 Canadians. In most cases, CML is caused by a mutation affecting chromosomes 22 and 9. So that date – 22/9 – has become a powerful symbol as the worldwide community unites to raise...

2014-09-22 23:04:28

“The Race is On!” for the 22nd Susan G. Komen Phoenix Race for the Cure® on Sunday, October 12, 2014 as it moves to its new location at Cesar Chavez Plaza in downtown Phoenix. Phoenix, Arizona (PRWEB) September 22, 2014 “The Race is On!” for the 22nd Susan G. Komen Phoenix Race for the Cure® on Sunday, October 12, 2014 as it moves to its new location at Cesar Chavez Plaza in downtown Phoenix. As the signature fundraising and awareness event for Susan G. Komen®...

2014-09-22 23:02:33

The Firm is investigating potential legal claims on behalf of women who allegedly experienced the spread of uterine sarcomas and other cancers due to uterine morcellation. New York, New York (PRWEB) September 22, 2014 As concerns about the potential risks associated with the use of power morcellators (http://www.gynecaremorcellatorlawsuit.com/) in gynecological surgeries mount, Bernstein Liebhard LLP notes a new report detailing the continued use of uterine morcellation by some doctors,...

2014-09-22 08:29:14

FDA Submission Reinforces Commitment to Addressing Significant Unmet Needs for Patients With Acute Lymphoblastic Leukemia, an Aggressive Cancer With Limited Treatment Options THOUSAND OAKS, Calif., Sept. 22, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) seeking approval for its investigational bispecific T cell engager (BiTE(®)) antibody construct, blinatumomab. The BLA is...

2014-09-22 08:27:32

LOS ANGELES, Sept. 22, 2014 /PRNewswire/ -- CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced that study designs and progress from two of the Company's key clinical trials of aldoxorubicin, a pivotal global Phase 3 clinical trial in relapsed/refractory soft tissue sarcomas (STS) and a global Phase 2b clinical trial in small cell lung cancer, will be presented at the European Society for Medical Oncology...

2014-09-22 04:21:55

LUGANO, Switzerland, September 22, 2014 /PRNewswire/ -- Helsinn Group, a company focused on building quality cancer care, today announces that it is supporting an independent educational satellite symposium on Delivering Chemotherapy With Confidence: New Strategies to Minimize Treatment-Induced Nausea and Vomiting at the 38th European Society for Medical Oncology (ESMO) Congress in Madrid, Spain, in 2014. Helsinn has awarded a grant to prIME oncology, a global...

2014-09-20 23:02:11

The Firm is evaluating legal claims on behalf of women who experienced the spread of uterine sarcoma and other cancers, allegedly due to uterine morcellation. New York, New York (PRWEB) September 20, 2014 As concerns surrounding the use of power morcellators (http://www.injurybeacon.com/power-morcellator/) in gynecological surgeries continue to grow, Bernstein Liebhard LLP notes that yet another insurer has announced plans to end coverage for uterine morcellation. According to a...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related